• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

计算鉴定潜在的多靶点治疗方法,以改善淀粉样蛋白-β对突触可塑性的不良影响。

Computational identification of potential multitarget treatments for ameliorating the adverse effects of amyloid-β on synaptic plasticity.

机构信息

Department of Molecular and Integrative Physiology, Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign Urbana, IL, USA.

出版信息

Front Pharmacol. 2014 May 8;5:85. doi: 10.3389/fphar.2014.00085. eCollection 2014.

DOI:10.3389/fphar.2014.00085
PMID:24847263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4021136/
Abstract

The leading hypothesis on Alzheimer Disease (AD) is that it is caused by buildup of the peptide amyloid-β (Aβ), which initially causes dysregulation of synaptic plasticity and eventually causes destruction of synapses and neurons. Pharmacological efforts to limit Aβ buildup have proven ineffective, and this raises the twin challenges of understanding the adverse effects of Aβ on synapses and of suggesting pharmacological means to prevent them. The purpose of this paper is to initiate a computational approach to understanding the dysregulation by Aβ of synaptic plasticity and to offer suggestions whereby combinations of various chemical compounds could be arrayed against it. This data-driven approach confronts the complexity of synaptic plasticity by representing findings from the literature in a course-grained manner, and focuses on understanding the aggregate behavior of many molecular interactions. The same set of interactions is modeled by two different computer programs, each written using a different programming modality: one imperative, the other declarative. Both programs compute the same results over an extensive test battery, providing an essential crosscheck. Then the imperative program is used for the computationally intensive purpose of determining the effects on the model of every combination of ten different compounds, while the declarative program is used to analyze model behavior using temporal logic. Together these two model implementations offer new insights into the mechanisms by which Aβ dysregulates synaptic plasticity and suggest many drug combinations that potentially may reduce or prevent it.

摘要

阿尔茨海默病(AD)的主要假说认为,它是由肽淀粉样蛋白-β(Aβ)的积累引起的,Aβ 最初导致突触可塑性失调,最终导致突触和神经元的破坏。限制 Aβ 积累的药物治疗已被证明无效,这带来了双重挑战,即了解 Aβ 对突触的不良影响,并提出预防这些影响的药物治疗方法。本文旨在启动一种计算方法来理解 Aβ 对突触可塑性的失调,并提供建议,通过这些建议可以对抗 Aβ 的各种化合物组合。这种数据驱动的方法通过以粗粒度的方式表示文献中的发现来应对突触可塑性的复杂性,并侧重于理解许多分子相互作用的总体行为。同一组相互作用由两个不同的计算机程序建模,每个程序都使用不同的编程模式编写:一个是命令式的,另一个是声明式的。两个程序都在广泛的测试电池上计算相同的结果,提供了必要的交叉检查。然后,命令式程序用于确定模型中十种不同化合物的每种组合对模型的影响,而声明式程序用于使用时间逻辑分析模型行为。这两个模型实现共同为 Aβ 如何失调突触可塑性的机制提供了新的见解,并提出了许多潜在的药物组合,这些组合可能会减少或预防这种失调。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4d9/4021136/924925b8b89d/fphar-05-00085-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4d9/4021136/d7526e576539/fphar-05-00085-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4d9/4021136/924925b8b89d/fphar-05-00085-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4d9/4021136/d7526e576539/fphar-05-00085-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4d9/4021136/924925b8b89d/fphar-05-00085-g0002.jpg

相似文献

1
Computational identification of potential multitarget treatments for ameliorating the adverse effects of amyloid-β on synaptic plasticity.计算鉴定潜在的多靶点治疗方法,以改善淀粉样蛋白-β对突触可塑性的不良影响。
Front Pharmacol. 2014 May 8;5:85. doi: 10.3389/fphar.2014.00085. eCollection 2014.
2
Exploring the contribution of estrogen to amyloid-Beta regulation: a novel multifactorial computational modeling approach.探索雌激素对淀粉样蛋白-β调节的贡献:一种新的多因素计算建模方法。
Front Pharmacol. 2013 Mar 1;4:16. doi: 10.3389/fphar.2013.00016. eCollection 2013.
3
Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.人脑源性β淀粉样蛋白寡聚体以一种需要淀粉样前体蛋白(APP)的方式与突触结合并破坏突触活动。
J Neurosci. 2017 Dec 6;37(49):11947-11966. doi: 10.1523/JNEUROSCI.2009-17.2017. Epub 2017 Nov 3.
4
Effect of Aβ Oligomers on Neuronal APP Triggers a Vicious Cycle Leading to the Propagation of Synaptic Plasticity Alterations to Healthy Neurons.Aβ 寡聚体对神经元 APP 的影响引发了一个恶性循环,导致突触可塑性改变向健康神经元传播。
J Neurosci. 2020 Jul 1;40(27):5161-5176. doi: 10.1523/JNEUROSCI.2501-19.2020. Epub 2020 May 22.
5
Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.β-淀粉样蛋白对突触可塑性的破坏:潜在的阿尔茨海默病改善疗法的调节作用
Biochem Soc Trans. 2005 Aug;33(Pt 4):563-7. doi: 10.1042/BST0330563.
6
Bis(propyl)-cognitin Prevents β-amyloid-induced Memory Deficits as Well as Synaptic Formation and Plasticity Impairments via the Activation of PI3-K Pathway.双(丙基)-认知素通过激活PI3-K途径预防β-淀粉样蛋白诱导的记忆缺陷以及突触形成和可塑性损伤。
Mol Neurobiol. 2016 Aug;53(6):3832-3841. doi: 10.1007/s12035-015-9317-9. Epub 2015 Jul 10.
7
Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.在阿尔茨海默病小鼠模型中通过β-分泌酶1逆向转运调控突触淀粉样β蛋白的生成
J Neurosci. 2017 Mar 8;37(10):2639-2655. doi: 10.1523/JNEUROSCI.2851-16.2017. Epub 2017 Feb 3.
8
Computational identification of potential multi-drug combinations for reduction of microglial inflammation in Alzheimer disease.用于减少阿尔茨海默病中小胶质细胞炎症的潜在多药联合疗法的计算识别
Front Pharmacol. 2015 Jun 5;6:116. doi: 10.3389/fphar.2015.00116. eCollection 2015.
9
Synaptic Plasticity, Dementia and Alzheimer Disease.突触可塑性、痴呆和阿尔茨海默病。
CNS Neurol Disord Drug Targets. 2017;16(3):220-233. doi: 10.2174/1871527316666170113120853.
10
Effect of troxerutin on synaptic plasticity of hippocampal dentate gyrus neurons in a β-amyloid model of Alzheimer׳s disease: an electrophysiological study.曲克芦丁对阿尔茨海默病β-淀粉样蛋白模型中海马齿状回神经元突触可塑性的影响:一项电生理研究
Eur J Pharmacol. 2014 Jun 5;732:19-25. doi: 10.1016/j.ejphar.2014.03.018. Epub 2014 Mar 25.

引用本文的文献

1
Altered synaptic plasticity at hippocampal CA1-CA3 synapses in Alzheimer's disease: integration of amyloid precursor protein intracellular domain and amyloid beta effects into computational models.阿尔茨海默病中海马体CA1-CA3突触处突触可塑性的改变:将淀粉样前体蛋白细胞内结构域和β淀粉样蛋白的作用整合到计算模型中。
Front Comput Neurosci. 2023 Dec 7;17:1305169. doi: 10.3389/fncom.2023.1305169. eCollection 2023.
2
Bridging Scales in Alzheimer's Disease: Biological Framework for Brain Simulation With The Virtual Brain.阿尔茨海默病中的跨尺度关联:利用虚拟大脑进行脑模拟的生物学框架
Front Neuroinform. 2021 Apr 1;15:630172. doi: 10.3389/fninf.2021.630172. eCollection 2021.
3

本文引用的文献

1
Pre- and postsynaptic twists in BDNF secretion and action in synaptic plasticity.BDNF 分泌和作用的突触前和突触后扭曲在突触可塑性中。
Neuropharmacology. 2014 Jan;76 Pt C:610-27. doi: 10.1016/j.neuropharm.2013.05.043. Epub 2013 Jun 18.
2
Bapineuzumab and solanezumab for Alzheimer's disease: is the 'amyloid cascade hypothesis' still alive?巴喷丁和索拉珠单抗治疗阿尔茨海默病:淀粉样蛋白级联假说是否仍然成立?
Expert Opin Biol Ther. 2013 Jul;13(7):1075-84. doi: 10.1517/14712598.2013.789856. Epub 2013 Apr 10.
3
Bapineuzumab alters aβ composition: implications for the amyloid cascade hypothesis and anti-amyloid immunotherapy.
Opportunities for multiscale computational modelling of serotonergic drug effects in Alzheimer's disease.
阿尔茨海默病中 5-羟色胺能药物作用的多尺度计算建模机会。
Neuropharmacology. 2020 Sep 1;174:108118. doi: 10.1016/j.neuropharm.2020.108118. Epub 2020 May 4.
4
Exploring the Correlation between the Cognitive Benefits of Drug Combinations in a Clinical Database and the Efficacies of the Same Drug Combinations Predicted from a Computational Model.探讨临床数据库中药物组合的认知益处与计算模型预测的相同药物组合疗效之间的相关性。
J Alzheimers Dis. 2019;70(1):287-302. doi: 10.3233/JAD-190144.
5
Computational modeling and biomarker studies of pharmacological treatment of Alzheimer's disease (Review).计算建模与生物标志物研究在阿尔茨海默病药物治疗中的应用(综述)。
Mol Med Rep. 2018 Jul;18(1):639-655. doi: 10.3892/mmr.2018.9044. Epub 2018 May 22.
6
Capturing intracellular Ca dynamics in computational models of neurodegenerative diseases.在神经退行性疾病的计算模型中捕捉细胞内钙动力学。
Drug Discov Today Dis Models. 2016 Spring;19:37-42. doi: 10.1016/j.ddmod.2017.02.005. Epub 2017 Mar 18.
巴喷丁单抗改变了淀粉样蛋白组成:对淀粉样蛋白级联假说和抗淀粉样蛋白免疫疗法的影响。
PLoS One. 2013;8(3):e59735. doi: 10.1371/journal.pone.0059735. Epub 2013 Mar 21.
4
Exploring the contribution of estrogen to amyloid-Beta regulation: a novel multifactorial computational modeling approach.探索雌激素对淀粉样蛋白-β调节的贡献:一种新的多因素计算建模方法。
Front Pharmacol. 2013 Mar 1;4:16. doi: 10.3389/fphar.2013.00016. eCollection 2013.
5
An N-terminal fragment of the prion protein binds to amyloid-β oligomers and inhibits their neurotoxicity in vivo.朊病毒蛋白的 N 端片段与淀粉样β寡聚物结合,并在体内抑制其神经毒性。
J Biol Chem. 2013 Mar 15;288(11):7857-7866. doi: 10.1074/jbc.M112.423954. Epub 2013 Jan 28.
6
Alzheimer's therapeutics: continued clinical failures question the validity of the amyloid hypothesis-but what lies beyond?阿尔茨海默病治疗学:持续的临床失败对淀粉样蛋白假说的有效性提出质疑——但除此之外还有什么?
Biochem Pharmacol. 2013 Feb 1;85(3):289-305. doi: 10.1016/j.bcp.2012.11.014. Epub 2012 Nov 23.
7
Treatment strategies targeting amyloid β-protein.靶向淀粉样β蛋白的治疗策略。
Cold Spring Harb Perspect Med. 2012 Sep 1;2(9):a006387. doi: 10.1101/cshperspect.a006387.
8
Targeting synaptic dysfunction in Alzheimer's disease therapy.靶向阿尔茨海默病治疗中的突触功能障碍。
Mol Neurobiol. 2012 Dec;46(3):572-87. doi: 10.1007/s12035-012-8324-3. Epub 2012 Aug 23.
9
Absence of amyloid β oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer's disease neuropathology.认知功能正常的阿尔茨海默病病理患者的突触后不存在淀粉样 β 寡聚体和调节性突触 Zn2+。
Mol Neurodegener. 2012 May 28;7:23. doi: 10.1186/1750-1326-7-23.
10
Striatal-enriched protein-tyrosine phosphatase (STEP) regulates Pyk2 kinase activity.纹状体丰富的蛋白酪氨酸磷酸酶(STEP)调节 Pyk2 激酶活性。
J Biol Chem. 2012 Jun 15;287(25):20942-56. doi: 10.1074/jbc.M112.368654. Epub 2012 Apr 27.